Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yuxin Mu
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0000-0002-8465-6933
Observed ORCID:
0000-0002-8465-6933
OpenAlex ID:
A5122755656
Results and Exploratory Biomarker Analyses of a Phase II Study CHANGEABLE: Combination of PD‐1 Inhibitor and Niraparib in GErm‐Line‐mutAted Metastatic Breast Cancer
2026
·
Jian Zhang
, Yiqun Du
, et al.
·
MedComm
·
2
Granisetron transdermal delivery system versus palonosetron in the prevention of long-delayed nausea and vomiting: a phase III randomized trial
2026
·
Xiaojun Liu
, Yanchun Meng
, et al.
·
The Oncologist
·
2
Reduced/No Dexamethasone With Netupitant/Palonosetron and Olanzapine for Chemotherapy‑Induced Nausea/Vomiting in Highly Emetogenic Chemotherapy: Phase III Noninferiority Trial
2026
·
Yanchun Meng
, Yingying Liu
, et al.
·
Journal of Clinical Oncology
·
1
Data-driven precision prognostic stratification in breast cancer leptomeningeal metastasis: The BC-LGPA model and treatment refinement.
2026
·
Jian Zhang
, Yuxin Yan
, et al.
·
Journal of Clinical Oncology
PDF
Tumor Microenvironment in Triple-Negative Breast Cancer and Targeting Approaches
2026
·
Youli Li
, Yang Chen
, et al.
·
Cancer Biome and Targeted Therapy
PDF
Show more works
View as search
Works count:
5
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type